
Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today our funds are larger and more global, but our teams are still small and local. We stay true to our entrepreneurial roots. In the US and Europe, we are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, our sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together we bring a world of insight, domain expertise and relationships to support our entrepreneurs. Without the pressure of fundraising from outside investors, we focus all of our time finding and helping great entrepreneurs build important companies.
我們正在追蹤 F-Prime 的市場擴張
F-Prime 的國際擴張與競爭對手的比較
長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
F-Prime你 | 0 | 0 | — | 0 | 0 |
目前並無招聘
註冊以追蹤此公司,並在發生變化時第一時間獲得提醒。
We’re thrilled to share our Behind the Breakthrough conversation with Kai Eberhardt, Co-Founder and CEO of Oviva—the leading virtual clinic for weight-related conditions in Europe. Oviva combines advanced technology with personalized coaching to help people make lasting lifestyle changes and improve their health.Discover how Oviva’s integrated care model closes healthcare gaps, making support more accessible and equitable, while Kai highlights the power of compassion, NHS credibility, and AI-dri ...
已結束FDA授予OnCusp Therapeutics的CUSP06快速通道資格,用於治療鉑耐藥性卵巢癌,加速開發這種有前景的療法。
拉丁美洲金融科技公司 Toku 獲得由 Oak HC/FT 領投的 4800 萬美元 A 輪融資,總融資額達 5500 萬美元。
波士頓的Almanac Health獲得由F-Prime領投的1000萬美元種子輪融資,General Catalyst和Lightspeed參與,總融資額達1200萬美元,用於其臨床AI平台。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 F-Prime 業務、市場及增長訊號的快速解答。
